Immune‐mediated drug‐induced liver injury secondary to Omeprazole: A case report

Immune‐mediated drug‐induced liver injury secondary to Omeprazole: A case report

Abstract Omeprazole is a rare cause of DILI with autoimmune hepatitis features and should be considered when seeing patients with acute liver injury. The causative drug should be promptly identified and discontinued to avoid any permanent liver damage.

Bibliographic Details
Main Authors: Sara Seife Hassen, Fateen Ata, Ammara Bint I Bilal, Mohamed Salih Ali, Mahir Petkar, Abdelnaser Y. Awad Elzouki, Muhammad Zahid
Format: Article
Language:English
Published: Wiley 2020-12-01
Series:Clinical Case Reports
Subjects:
autoimmune hepatitis
drug‐induced liver injury
omeprazole
proton pump inhibitors
Online Access:https://doi.org/10.1002/ccr3.3421
id doaj-603638af58ad4cc5a9e5eec8e32b1d9a
record_format Article
spelling doaj-603638af58ad4cc5a9e5eec8e32b1d9a2021-08-02T06:23:39ZengWileyClinical Case Reports2050-09042020-12-018123420342510.1002/ccr3.3421Immune‐mediated drug‐induced liver injury secondary to Omeprazole: A case reportSara Seife Hassen0Fateen Ata1Ammara Bint I Bilal2Mohamed Salih Ali3Mahir Petkar4Abdelnaser Y. Awad Elzouki5Muhammad Zahid6Department of Internal Medicine Hamad General Hospital Hamad Medical Corporation Doha QatarDepartment of Internal Medicine Hamad General Hospital Hamad Medical Corporation Doha QatarDepartment of Radiology Hamad General Hospital Hamad Medical Corporation Doha QatarDepartment of Internal Medicine Hamad General Hospital Hamad Medical Corporation Doha QatarDepartment of Pathology Hamad General Hospital Hamad Medical Corporation Doha QatarDepartment of Internal Medicine Hamad General Hospital Hamad Medical Corporation Doha QatarDepartment of Internal Medicine Hamad General Hospital Hamad Medical Corporation Doha QatarAbstract Omeprazole is a rare cause of DILI with autoimmune hepatitis features and should be considered when seeing patients with acute liver injury. The causative drug should be promptly identified and discontinued to avoid any permanent liver damage.https://doi.org/10.1002/ccr3.3421autoimmune hepatitisdrug‐induced liver injuryomeprazoleproton pump inhibitors
collection DOAJ
language English
format Article
sources DOAJ
author Sara Seife Hassen
Fateen Ata
Ammara Bint I Bilal
Mohamed Salih Ali
Mahir Petkar
Abdelnaser Y. Awad Elzouki
Muhammad Zahid
spellingShingle Sara Seife Hassen
Fateen Ata
Ammara Bint I Bilal
Mohamed Salih Ali
Mahir Petkar
Abdelnaser Y. Awad Elzouki
Muhammad Zahid
Immune‐mediated drug‐induced liver injury secondary to Omeprazole: A case report
Clinical Case Reports
autoimmune hepatitis
drug‐induced liver injury
omeprazole
proton pump inhibitors
author_facet Sara Seife Hassen
Fateen Ata
Ammara Bint I Bilal
Mohamed Salih Ali
Mahir Petkar
Abdelnaser Y. Awad Elzouki
Muhammad Zahid
author_sort Sara Seife Hassen
title Immune‐mediated drug‐induced liver injury secondary to Omeprazole: A case report
title_short Immune‐mediated drug‐induced liver injury secondary to Omeprazole: A case report
title_full Immune‐mediated drug‐induced liver injury secondary to Omeprazole: A case report
title_fullStr Immune‐mediated drug‐induced liver injury secondary to Omeprazole: A case report
title_full_unstemmed Immune‐mediated drug‐induced liver injury secondary to Omeprazole: A case report
title_sort immune‐mediated drug‐induced liver injury secondary to omeprazole: a case report
publisher Wiley
series Clinical Case Reports
issn 2050-0904
publishDate 2020-12-01
description Abstract Omeprazole is a rare cause of DILI with autoimmune hepatitis features and should be considered when seeing patients with acute liver injury. The causative drug should be promptly identified and discontinued to avoid any permanent liver damage.
topic autoimmune hepatitis
drug‐induced liver injury
omeprazole
proton pump inhibitors
url https://doi.org/10.1002/ccr3.3421
work_keys_str_mv AT saraseifehassen immunemediateddruginducedliverinjurysecondarytoomeprazoleacasereport
AT fateenata immunemediateddruginducedliverinjurysecondarytoomeprazoleacasereport
AT ammarabintibilal immunemediateddruginducedliverinjurysecondarytoomeprazoleacasereport
AT mohamedsalihali immunemediateddruginducedliverinjurysecondarytoomeprazoleacasereport
AT mahirpetkar immunemediateddruginducedliverinjurysecondarytoomeprazoleacasereport
AT abdelnaseryawadelzouki immunemediateddruginducedliverinjurysecondarytoomeprazoleacasereport
AT muhammadzahid immunemediateddruginducedliverinjurysecondarytoomeprazoleacasereport
_version_ 1721240187574419456

Similar Items